The DD-ACE genotype and cardiovascular disease

Pharmacogenomics

Volumn 1, Issue 2, 2000, Pages 153-167

  Butler, R ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Cardiac risk factors; Cardiovascular disease; DD genotype; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOENZYME;

ALLELE; ANIMAL; CARDIOVASCULAR DISEASE; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; HUMAN; REVIEW;

ALLELES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; ISOENZYMES; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 0034189487     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.1.2.153     Document Type: Review

References (102)

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N. Engl. J. Med. (1991) 325:293-302.
2. PFEFFER MA, BRAUNWALD E, MOYE LA et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N. Engl. J. Med. (1992) 327:669-677.
3. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet (1993) 342:821-828.
4. RIGAT B, HUBERT C, ALHENC-GELAS F et al.: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Inv. (1990) 86:1343-1346.
5. CAMBIEN F, POIRIER O, LECERF L et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (1992) 359:641-644.
6. ERDOS EG, SKIDGEL RA: The angiotensin I-converting enzyme. Lab. Invest. (1987) 56:345-348.
7. DAS M, HARTLEY JL, SOFFERS RL: Serum angiotensin-converting enzyme. Isolation and relationship to the pulmonary enzyme. J. Biol. Chem.(1977) 252:1316-1319.
8. SHANMUGAM V, SELL KW, SAHA BK: Mistyping ACE heterozygotes. Genome Res. (1993) 3:120-121.
9. LINDPAINTNER K, PFEFFER MA, KREUTZ R et al.: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. (1995) 332:706-711.
10. BLOEM LJ, MANATUNGA AK, PRATT JH: Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension (1996) 27:62-66.
11. SAVAGE DD, WATKINS LO, GRIM CE, KUMINYIKA SK: Hypertension in black populations. In: Hypertension, Pathophysiology, Diagnosis and Management Laragh JH, Brenner BM (Eds.), Raven Press, New York, USA (1990):1837-1852.
12. MCKENZIE CA, JULIER C, FORRESTER T et al.: Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am. J. Hum. Genet.(1995) 57:1426-1435.
13. MATTU RK, NEEDHAM EW, GALTON DJ et al: A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation (1995) 91:270-274.
14. EVANS AE, POIRIER O, KEE F et al.: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q. J. Med. (1994) 87:211-214.
15. NAKAI K, ITOH C, MIURA Y et al.: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation (1994) 90:2199-2202.
16. KAMITANI A, RAKUGI H, HIGAKI J et al.: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension (1995) 25:950-953.
17. ZHAO Y, HIGASHIMORI K, HIGAKI J et al.: Significance of deletion polymorphism of the angiotensin-converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens. Res. (1994) 17:55-57.
18. FUJISAWA T, IKEGAMI H, SHEN GQ et al: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diab. Care (1995) 18:983-985.
19. GARDEMANN A, FINK M, STRICKER J et al.: ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis (1998) 139:153-159.
20. ARBUSTINI E, GRASSO M, FASANI R et al: Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br. Heart J. (1995) 74:584-591.
21. SAMANI NJ, THOMPSON JR, O'TOOLE L, CHANNER K, WOODS KL: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation (1996) 94:708-712.
22. SAMANI NJ, O'TOOLE L, MARTIN D et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J. Am. Coll. Cardiol. (1996) 28:338-344.
23. BOHN M, BERGE KE, BAKKEN A, ERIKSSEN J, BERG K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin. Genetics (1993) 44:292-297.
24. AGERHOLM-LARSEN B, NORDESTGAARD BG, STEFFENSEN R, SORENSEN KE: The angiotensin-converting enzyme gene polymorphism fails to predict coronary heart disease in a case cohort study of 7300 individuals. Circulation (1995) 92:3849.
25. AGERHOLM-LARSEN B, NORDESTGAARD BG, STEFFENSEN R et al.: ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study Circulation (1997) 95:2358-2367.
26. WINKELMANN BR, NAUCK M, KLEIN B et al.: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann. Int. Med. (1996) 125:19-25.
27. FRIEDL W, KREMPLER F, PAULWEBER B, PICHLER M, SANDHOFER F: A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis (1995) 112:137-143.
28. CHOUDHURY TA, DRONSFIELD MJ, JONES AF, BAIN SC: Angiotensin II receptor gene polymorphisms and risk of myocardial infarction. Lancet (1994) 344:1502-1503.
29. LUDWIG E, CORNELI PS, ANDERSON JL et al.: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 91:2120-2124.
30. RAYNOLDS MV, BRISTOW MR, BUSH EW et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (1993) 342:1073-1075.
31. SINGER DR, MISSOURIS CG, JEFFERY S: Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. Circulation (1996) 94:236-239.
32. KATSUYA T, KOIKE G, YEE TW et al.: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 345:1600-1603.
33. SCHUSTER H, WIENKER TF, STREMMLER U et al.: An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women but not in men Am. J. Cardiol. (1995) 76:601-603.
34. STAESSEN JA, WANG JG, GINOCCHIO G et al.: The deletion/insertion polymorphism of the anglotensin converting enzyme gene and cardiovascular-renal risk J. Hypertens. (1997) 15:1579-1592.
35. WINKELMANN BR, VERHO M: ACE*D and cardiovascular disease. Circulation (1997) 96:1050-1052.
36. TUKEY JW: Some thoughts on clinical trials, especially problems of multiplicity. Science (1997) 198:679-684.
37. GAMBARO G, ANGLANI F, D'ANGELO A: Association studies of genetic polymorphisms and complex disease. Lancet (2000) 355:308-311.
38. NAGASHIMA J, MUSHA H, SO T et al.: Effect of angiotensin-converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction. Clin. Cardiol. (1999) 22:587-590.
39. HENRION D, BENESSIANO J, PHILIP I et al.: The deletion genotype of the angiotensIn I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro. J. Am. Coll. Cardiol. (1999) 34:830-836.
40. YOSHIDA M, IWAI N, OHMICHI N et al.: D allele of the angiotensin-converting enzyme gene is a risk factor for secondary cardiac events after myocardial infarction. Int. J. Cardiol. (1999) 70:119-125.
41. O'MALLEY JP, MASLEN CL, ILLINGWORTH DR: Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia. Circulation(1998) 97:1780-1783.
42. TIRET L, KEE F, POIRIER O et al.: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet (1993) 341:991-992.
43. BADENHOP RF, WANG XL, WILCKEN DE: Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation (1995) 91:1655-1658.
44. MARKUS HS, BARLEY J, LUNT R et al.: Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma [see comments]. Stroke (1995) 26:1329-1333.
45. MARGAGLIONE M, CELENTANO E, GRANDONE E et al.: Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arteriosclerosis, Thromb. Vascular Biol. (1996) 16:304-309.
46. CUNNINGHAM DA, CRISP SJ, BARBIR M et al.: Donor ACE gene polymorphism: a genetic risk factor for accelerated coronary sclerosis following cardiac transplantation. Eur. Heart J. (1998) 19:319-325.
47. OIKE Y, HATA A, OGATA Y et al.: Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. J. Clin. Inv. (1995) 96:2975-2979.
48. KUROKIS, IKEDA U, MAEDA Y, SEKIGUCHI H, SHIMADA K: Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and vasospastic angina. Clin. Cardiol. (1997) 20:873-876.
49. PINTO YM, VAN GILST WH, KINGMA JH, SCHUNKERT H: Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators [see comments]. J. Am. Coll. Cardiol. (1995) 25:1622-1626.
50. OHMICHI N, IWAI N, NAKAMURA Y, KINOSHITA M: The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am. J. Cardiol. (1995) 76:326-329.
51. Deletion polymorphism of the angiotensin-converting enzyme gene associates with an increased risk for late potentials in patients with myocardial infarction. Circulation (1995) 92(Suppl.):3563.
52. SAMANI NJ, MARTIN DS, BRACK M et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angloplasty. Lancet (1995) 345:1013-1016.
53. HAMON M, BAUTERS C, AMANT C et al.: Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation (1995) 92:296-299.
54. BEOHAR N, DAMARAJU S, PRATHER A et al.: Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. J. Invest. Med. (1995) 43:275-280.
55. OHISHI M, FUJII K, MINAMINO T et al.: A potent genetic risk factor for restenosis. Nature Genet. (1993) 5:324-325.
56. HARRAP SB, DAVIDSON HR, CONNOR JM et al.: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension (1993) 21:455-460.
57. GU XX, SPAEPEN M, GUO C et al.: Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J. Hum. Hypertens. (1994) 8:683-685.
58. ELSAHAT YI, OBINECHE EN, LESTRINGENT GG, FROSSARD PM: An angiotensin-converting enzyme gene polymorphism does not correlate with hypertension in and Arab population for the United Arab Emirates. Am. J. Hum. Genet.(1995) 57(Suppl.):1379.
59. SCHUNKERT H, HENSE HW, HOLMER SR et al: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N. Engl. J. Med. (1994) 330:1634-1638.
60. LEVY D, GARRISON RJ, SAVAGE DD, KANNEL WB, CASTELLI WP: Prognostic implications of echocardio-graphically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. (1990) 322:1561-1566.
61. SULLIVAN JM, VANDER ZR, EL-ZEKY F, RAMANATHAN KB, MIRVIS DM: Left ventricular hypertrophy: effect on survival. J. Am. Coll. Cardiol. (1993) 22:508-513.
62. LEVY D, ANDERSON KM, SAVAGE DD et al.: Echocardio-graphically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann. Int. Med. (1988) 108:7-13.
63. IWAI N, OHMICHI N, NAKAMURA Y, KINOSHITA M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation (1994) 90:2622-2628.
64. CELENTANO A, MANCINI FP, CRIVARO M et al.: Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism and left ventricular mass in systemic hypertension. Am. J. Cardiol. (1999) 83:1196-1200.
65. PERTICONE F, CERAVOLO R, COSCO C et al.: Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J. Am. Coll. Cardiol. (1997) 29:365-369.
66. PRASAD N, O'KANE KP, JOHNSTONE HA et al.: The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q. J. Med. (1994) 87:659-662.
67. KUPARI M, PEROLA M, KOSKINEN P, VIROLAINEN J, KARHUNEN PJ: Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am. J. Physiol. (1994) 267:H1107-H1111.
68. KAUMA H, IKAHEIMO M, SAVOLAINEN MJ et al.: Variants of renin-angiotensin system genes and echocardiographic left ventricular mass. Eur. Heart J. (1998) 19:1109-1117.
69. KOHNO M, YOKOKAWA K, MINAMI M et al.: Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors. Am. J. Med. (1999) 106:544-549.
70. OHMICHI N, IWAI N, UCHIDA Y et al.: Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype. Am. J. Hypertens. (1997) 10:951-955.
71. VAN SUYLEN RJ, WOUTERS EF, PENNINGS HJ et al.: The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care Med. (1999) 159:1791-1795.
72. CANDY GP, SKUDICKY D, MUELLER UK et al.: Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am. J. Cardiol. (1999) 83:740-744.
73. MONTGOMERY HE, KEELING PJ, GOLDMAN JH et al.: Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. (1995) 25:1627-1631.
74. ANDERSSON B, SYLVEN C: The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J. Am. Coll. Cardiol. (1996) 28:162-167.
75. MARIAN AJ, YU QT, WORKMAN R, GREVE G, ROBERTS R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet (1993) 342:1085-1086.
76. YONEYA K, OKAMOTO H, MACHIDA M et al.: Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am. Heart. J. (1995) 130:1089-1093.
77. TIRET L, BONNARDEAUX A, POIRIER O et al.: Synergistic effects of angiotensin-converting enzyme and angiotensin-II Type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet (1994) 344:910-913.
78. ZEE RY, RIDKER PM, STAMPFER MJ, HENNEKENS CH, LINDPAINTNER K: Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation (1999) 99:340-343.
79. DESSI-FULGHERI P, CATALINI R, SARZANI R et al.: Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J. Hypertens. (1995) 13:1593-1596.
80. KOSTULAS K, HUANG WX, CRISBY M et al.: An angiotensin-converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis. Eur. J. Clin. Inv. (1999) 29:478-483.
81. BONITHON-KOPP C, DUCIMETIERE P, TOUBOUL PJ et al.: Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation (1994) 89:952-954.
82. TAUTE BM, HANDSCHUG K, TAUTE R et al.: Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease. Vasa (1998) 27:149-153.
83. TAYLOR RR, MAMOTTE CD, FALLON K, VAN BOCKXMEER FM: Elite athletes and the gene for anglotensin-converting enzyme. J. Appl. Physiol. (1999) 87:1035-1037.
84. MONTGOMERY HE, CLARKSON P, DOLLERY CM et al.: Association of anglotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation (1997) 96:741-747.
85. 2 max is associated with ACE genotype in postmenopausal women. J. Appl. Physiol. (1998) 85:1842-1846.
86. LACHURIE ML, AZIZI M, GUYENE TT, ALHENC-GELAS F, MENARD J: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation (1995) 91:2933-2942.
87. UEDA S, ELLIOTT HL, MORTON JJ, CONNELL JM: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension (1995) 25:1266-1269.
88. BUIKEMA H, PINTO YM, ROOKS G et al.: The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries. Eur. Heart J. (1996) 17:787-794.
89. O'KANE KP, WEBB DJ, COLLIER JG, VALLANCE PJ: Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br. J. Clin. Pham. (1994) 38:311-315.
90. BROWN NJ, BLAIS CJ, GANDHI SK, ADAM A: ACE insertion/deletion genotype affects bradykinin metabolism. J. Card. Pharmacol. (1998) 32:373-377.
91. ZEIHER AM, SCHACHINGER V, MINNERS J, HALLE M, ROSCHMANN E: Angiotensin-converting enzyme gene deletion polymorphism is associated with impaired coronary endothelial function. Circulation (1995) 92(Suppl.):1-96.
92. BUTLER R, MORRIS AD, BURCHELL B, STRUTHERS AD: DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension (1999) 33:1164-1168.
93. CELERMAJER DS, SORENSEN KE, BARLEY J et al.: Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis (1994) 111:121-126.
94. BERNTORP K, LINDGARDE F, MATTIASSON I: Long-term effects on insulin sensitivity and sodium transport in glucose-intolerant hypertensive subjects when beta-blockade is replaced by captopril treatment. J Hum. Hypertens. (1992) 6:291-298.
95. BARON AD: Hemodynamic actions of insulin. Am. J. Physiol. (1994) 267:E187-E202.
96. RUIZ J, BLANCHE H, COHEN N et al.: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA (1994) 91:3662-3665.
97. PANAHLOO A, ANDRES C, MOHAMED-ALI V et al.: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation (1995) 92:3390-3393.
98. MATTHEWS DR, HOSKER JP, RUDENSKI AS et al.: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 28:412-419.
99. KATSUYA T, HORIUCHI M, CHEN YD et al.: Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia. Arteriosclerosis, Thromb. Vascular Biol. (1995) 15:779-782.
100. KENNON B, PETRIE JR, SMALL M, CONNELL JM: Angiotensin-converting enzyme gene and diabetes mellitus. Diab. Med. (1999) 16:448-458.
101. TSUKADA K, ISHIMITSU T, TSUCHIYA N, HORINAKA S, MATSUOKA H: Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system ta coronary anglography patients. Jpn. Heart J. (1997) 38:799-810.
102. KIM DK, KIM JW, KIM S et al.: Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arteriosclerosis, Thromb. Vascular Biol. (1997) 17:3242-3247.